← FDA Drug Approvals (Drugs@FDA)
LYNAVOY
NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 2026-03-17
Drug application
- FDA Application #
NDA220295- Application type
- New Drug Application
- Brand name
- LYNAVOY
- Generic name
- Linerixibat
- Active ingredients
- LINERIXIBAT
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- GLAXOSMITHKLINE
- First approval
- 2026-03-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown